Preparation and evaluation of an oral delivery system for time-dependent colon release of insulin and selected protease inhibitor and absorption enhancer compounds

• Published in: Journal of pharmaceutical sciences 2009-12, Vol.98 (12), p.4661-4669
• Main Authors: Del Curto, Maria Dorly, Maroni, Alessandra, Foppoli, Anastasia, Zema, Lucia, Gazzaniga, Andrea, Sangalli, Maria Edvige
• Format: Article
• Language: English
• Subjects: absorption enhancer; Administration, Oral; Biological and medical sciences; Calorimetry; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; coating; Colon - metabolism; colonic drug delivery; compatibility; Drug Compounding; Drug Delivery Systems; Drug Incompatibility; Excipients; General pharmacology; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - pharmacokinetics; in vitro release; insulin; Insulin - administration & dosage; Insulin - pharmacokinetics; Intestinal Absorption - drug effects; Medical sciences; oral drug delivery; peptide delivery; Pharmaceutical technology. Pharmaceutical industry; Pharmacology. Drug treatments; protease inhibitor; Protease Inhibitors - administration & dosage; Protease Inhibitors - pharmacokinetics; Solubility; Tablets; Thermography
• ISSN: 0022-3549; 1520-6017
• DOI: 10.1002/jps.21761

The aim of this work was to prepare and evaluate an oral dosage form intended for time-dependent colon delivery of insulin along with a selected protease inhibitor (camostat mesilate) and absorption enhancer (sodium glycocholate). A previously described release platform, which had proven potentially suitable for the protein delivery, was exploited. Insulin compatibility with the above-mentioned adjuvants was preliminarily evaluated. For this purpose, the drug and its main degradation products were assayed by HPLC in insulin powder mixtures with camostat mesilate and/or sodium glycocholate stored 12 months at 4°C. No significant decrease in protein content or increase in degradation product percentages beyond Eur. Ph. 6th Ed. limits was highlighted. Moreover, calorimetric studies performed on physical and compacted binary insulin mixtures with camostat mesilate and sodium glycocholate showed that the thermal behavior of both adjuvants was unchanged. Subsequently, tablet cores with differing compositions were prepared and spray-coated with an aqueous HPMC solution in order to obtain pulsatile delivery systems. The coated units were demonstrated to concurrently release the drug and the adjuvants in a prompt and quantitative mode after consistent lag times. Based on these results, the device was proven a potential candidate for colon delivery of insulin and the selected adjuvants. © 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:4661–4669, 2009